CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,976,580
- in 4 filings, $5.0M under 10b5-1 plans
Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-01 | DAWES KAREN A Director | Sale | −851 | $285.44 | $243K | 93,921 |
| 2021-09-01 | DAWES KAREN A Director | Exercise or conversion · Stock Option (Right to Buy) | +3,459 | 0 | ||
| 2021-08-30 | KURIYEL RALF Senior VP, R&D | Sale | −4,001 | $282.13 | $1.1M | 17,354 |
| 2021-08-18 | DAWES KAREN A Director | Sale | −302 | $257.66 | $78K | 95,061 |
| 2021-08-18 | DAWES KAREN A Director | Sale | −634 | $258.91 | $164K | 94,427 |
| 2021-08-18 | DAWES KAREN A Director | Sale | −388 | $259.93 | $101K | 94,039 |
| 2021-08-18 | DAWES KAREN A Director | Sale | −78 | $260.91 | $20K | 93,961 |
| 2021-08-18 | DAWES KAREN A Director | Sale | +40 | $262.31 | $10K | 93,921 |
| 2021-08-17 | DAWES KAREN A Director | Sale | −924 | $251.15 | $232K | 111,953 |
| 2021-08-17 | DAWES KAREN A Director | Sale | −920 | $251.92 | $232K | 111,033 |
| 2021-08-17 | DAWES KAREN A Director | Sale | −4,665 | $253.34 | $1.2M | 106,368 |
| 2021-08-17 | DAWES KAREN A Director | Sale | −8,580 | $254.09 | $2.2M | 97,788 |
| 2021-08-17 | DAWES KAREN A Director | Sale | −2,231 | $255.07 | $569K | 95,557 |
| 2021-08-17 | DAWES KAREN A Director | Sale | −194 | $256.43 | $50K | 95,363 |
| 2021-08-17 | Hunt Anthony Chief Executive Officer | Gift | −1,000 | 189,495 | ||
| 2021-08-04 | RYAN THOMAS F JR Director | Sale | −780 | $250.50 | $195K | 971 |
| 2021-07-20 | DAWES KAREN A Director | Sale | −288 | $200.01 | $58K | 117,174 |
| 2021-07-20 | DAWES KAREN A Director | Sale | −806 | $201.37 | $162K | 116,368 |
| 2021-07-20 | DAWES KAREN A Director | Sale | −2,877 | $202.29 | $582K | 113,491 |
| 2021-07-20 | DAWES KAREN A Director | Sale | −614 | $203.11 | $125K | 112,877 |
Page 26 of 42 · 832 trades